tiprankstipranks
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
Holding RNAC?
Track your performance easily

Cartesian Therapeutics (RNAC) Cash flow

1,101 Followers

Cartesian Therapeutics Cash Flow

RNAC's free cash flow for Q3 2024 was $7.49M. For the 2024 fiscal year, RNAC's free cash flow was decreased by $-18.54M and operating cash flow was $13.69M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -39.96M$ -51.16M$ -31.63M$ -60.38M$ 34.88M$ -51.44M
Investing Cash Flow
$ -1.89M$ 34.61M$ -15.00M$ -17.14M$ -741.00K$ 229.00K
Financing Cash Flow
$ 181.73M$ -13.14M$ 39.22M$ 52.90M$ 14.43M$ 105.04M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 492.85M$ 78.29M$ 108.04M$ 115.44M$ 140.06M$ 37.68M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
-$ 1.85M$ 2.25M$ 2.00M$ 1.02M$ 1.22M
Issuance Of Capital Stock
$ 124.44M$ 231.00K$ 189.00K$ 52.12M$ 10.45M$ 28.00K
Issuance Of Debt
-$ -27.46M--$ 5.42M$ -2.80M
Repayment Of Debt
-$ -27.46M--$ -19.31M$ -2.80M
Free Cash Flow
$ -48.41M$ -51.37M$ -32.83M$ -61.47M$ 34.14M$ -51.36M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Cartesian Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis